Fast Company Design
Does Novo Nordisk’s slimmed down rebrand signal a new era of DTC revivalism?
Novo Nordisk, the Dandish drugmaker behind the weight-loss drugs Ozempic and Wegovy, announced it’s rebranding to “Novo” beginning this week. It’s part of a larger trend in healthcare branding .
Read at Fast Company Design ↗Related
Baby Teeth rebrands Royal Society of Arts with archival system and Dame Judi Dench film Design Week
Studio Blackburn’s new identity for folding bike icon Brompton cements the brand’s place in British engineering heritage BP&O
An Apple alum revamped GM’s truck interface for the screen fatigue era Fast Company Design
Marina Willer crafts letters with light and projection for BFI London Film Festival’s new identity and campaign It's Nice That
What this elegant redesign of a sparkling water brand teaches us about packaging in 2026 Creative Boom
